Mazaahir Kidwai et al.
FULL PAPERS
by NaCl gradient (0–1M dissolved in equilibrating buffer) at
a flow rate of 0.5 mLminÀ1 with each 1 mL fraction. Frac-
tions with laccase activity were pooled, desalted and assayed
for laccase activity.
1673.83 cmÀ1 (C=C); 1H NMR (DMSO-d6, 300 MHz): d=
0.96 (s, 3H, CH3), 1.16 (s, 3H, CH3), 4.86 (1H, s, C9-H),
6.66–9.20 (m, 17H, Ar), 9.97 (s, 2H. OH); 13C NMR
(DMSO-d6, 75 MHz): d=25.14, 29.13, 50.14, 111.64, 117.25,
122.43, 123.12, 123.96, 125.35, 126.39, 127.46, 127.53, 127.93,
128.78, 129.35, 130.38, 131.46, 148.35, 154.43, 164.56, 195.71.
Enzyme Assay
Supporting Information
Guaiacol was used as a substrate for assaying laccase activi-
ty.[16] One unit (U) of laccase was defined as the change in
absorbance of 0.01 mLÀ1 minÀ1 at 470 nm.
Additional experimental procedures and spectral data are
available as Supporting Information.
General Procedure for the Synthesis of 2H-
ChromenoACHTUNGTRENNUNG[2,3-d]pyrimidine-2,4(3H)-dione and
Tetrahydroxanthen-1-one
Acknowledgements
The authors (M. Kidwai and R. Poddar) are thankful to
CSIR New Delhi for providing finance assistance. The au-
thors (S. Diwaniyan and R.C. Kuhad) acknowledge the finan-
cial support from Department of Biotechnology, New Delhi,
India.
Catechol or hydroquinone (1 mmole) and chalcone (1.5
mmoles) were taken in 15 mL of buffer solution where THF
was added to dissolve the reactants. Then, purified laccase
(400U) was added to the resultant solution and stirred well.
0.5 mL of 30% H2O2 was added to oxygenate the reaction
mixture. The progress of the reaction was checked by TLC
examination at an interval of every 30 min. Upon comple-
tion of reaction, the reaction mixture was extracted with References
ethyl acetate (3ꢁ15). The organic layer was dried over
Na2SO4. The product was purified by column chromatogra-
phy using a mobile phase of hexane:ethyl acetate (80:20)
and recrystallized with ethanol. The aqueous phase was fur-
ther used for another run without any pre-treatment.
5,6-Dihydroxy-10-phenyl-9-oxa-1,3-diaza-anthracene-2,4-
dione (5a): HR-MS: m/z=324.2322 (M+); anal. calcd for
C17H10N2O5: C 62.96, N 8.64, H 3.73%; found: C 62.85, N
8.59, H 3.86%; IR (KBr pellet): n=3322.44 (OH), 3205.54
(NH), 1733.56 (C=O), 1672.34 cmÀ1 (C=O); 1H NMR
(DMSO-d6, 300 MHz): d=6.38–7.54 (m, 7H, Ar), 8.81 (s,
2H. OH), 9.85 (s, 1H, NH); 13C NMR (DMSO-d6, 75 MHz):
d=113.41,114.42, 115.68, 119.39, 128.39, 129.59, 131.47,
133.48, 135.82, 137.06, 143.25, 144.77, 164.18, 165.51, 166.99,
168.77, 191.20.
5,8-Dihydroxy-5-phenyl-9-oxa-1,3-diaza-anthracene-2,4-
dione (7a): HR-MS: m/z=324.1452 (M+); anal. calcd. for
C17H10N2O5: C 62.96, N 8.64, H 3.73%; found: C 62.75, N
8.69, H 3.76%; IR (KBr pellet): n=3312.24 (OH), 3203.45
(NH), 1730.65 (C=O), 1673.42 cmÀ1 (C=O); 1H NMR
(DMSO-d6, 300 MHz): d=6.38–8.20 (m, 7H, Ar), 8.90 (s,
2H. OH), 10.25 (s, 1H, NH); 13C NMR (DMSO-d6,
75 MHz): d=113.41, 114.42, 115.68, 119.39, 128.39, 129.59,
131.47, 133.48, 135.82, 137.06, 143.25, 144.77, 164.18, 165.51,
166.99, 168.77, 191.20.
[1] S. Murahashi, S. Ono, Y. Imada, Angew. Chem. 2002,
114, 2472–2474; Angew. Chem. Int. Ed. 2002, 41, 2366–
2368.
[2] a) G. A. Hamilton, in: Progress in Bioorganic Chemis-
try, (Eds.: E. T. Kaiser, F. J. Kezdy), Wiley, New York,
1971, Vol. 1, p 83; b) Xing-Chen, K. Tanaka, F. Yoneda,
Chem. Pharm. Bull. 1990, 38, 307–311.
[3] S. Naya, M. Miyagawa, M. Nitta, Tetrahedron 2005, 61,
4919–4930.
[4] F. Yoneda, R. Hirayama, M. Yamashita, J. Heterocycl.
Chem. 1982, 19, 301–303.
[5] D. J. Blythin, M. S. Domalski, Y. C. Kim, J. Kuo, J-H.
Liu, Heterocycles 1981, 16, 203–207.
[6] a) S. G. Burton, Current Organic Chem. 2003, 7, 1317–
1331; b) M. Kidwai, R. Poddar, Catal. Lett. 2008, 124,
311–317.
[7] M. Kidwai, S. Saxena, M. K. R. Khan, S. S. Thukral,
Bioorg. Med. Chem. Lett. 2005, 15, 4295–4298.
[8] F. Yoneda, R. Hirayama, M. Yamashita, Chem. Lett.
1980, 1157–1160.
[9] a) X. Chen, M. Nagata, K. Tanaka, F. Yoneda, J. Chem.
Soc. Chem. Commun. 1989, 44–45; b) J. M. Schaus,
D. L. Huser, R. D. Titus, Synth. Commun. 1990, 20,
3553.
7,8-Dihydroxy-3,3-dimethyl-9-phenyl-2,3,4,9-tetrahydro-
xanthen-1-one (13a): HR-MS: m/z=336.1211 (M+); anal.
calcd. for C21H20O4: C 74.98, H 5.99%; found: C 75.05, H
5.89%; IR (KBr pellet): n=3310.94 (OH), 1738.14 (C=O),
1674.65 cmÀ1 (C=C); 1H NMR (DMSO-d6, 300 MHz): d=
0.93 (s, 3H, CH3), 1.09 (s, 3H, CH3), 5.08 (1H, s, C9-H),
6.66–9.20 (m, 11H, Ar), 10.23 (s, 2H. OH); 13C NMR
(DMSO-d6, 75 MHz): d=25.01, 29.18, 50.21, 111.84, 117.31,
122.56, 123.24, 123.84, 125.68, 126.89, 127.51, 127.62, 127.84,
128.36, 129.46, 130.12, 131.25, 148.51, 154.67, 164.56, 195.71.
5,8-Dihydroxy-3,3-dimethyl-9-phenyl-2,3,4,9-tetrahydro-
xanthen-1-one (14a): HR-MS: m/z=336.1211 (M+); anal.
calcd. for C21H20O4: C 74.98, H 5.99%; found: C 75.05, H
5.89%; IR (KBr pellet): n=3310.94 (OH), 1738.14 (C=O),
[10] a) S. Witayakran, A. J. Ragauskas, Green Chem. 2007,
9, 475–480; b) S. Witayakran, A. Zettili, A. J. Ragaus-
kas, Tetrahedron Lett. 2007, 48, 2983–2987.
[11] N. W. Fadnavis, A. Deshpande, Current Org. Chem.
2002, 6, 393–410.
[12] a) A. R. Stoit, J. H. M. Lange, A. P. Den Hartog, E.
Ronken, K. Tipker, H. H. V. Stuivenberg, J. A. R.
Dijksman, H. C. Wals, C. G. Kruse, Chem. Pharm. Bull.
2002, 50, 1109–1113; b) K. J. Shin, K. D. Koo, K. H.
Yoo, Y. K. Kang, S. W. Park, D. J. Kim, Bioorg. Med.
Chem. Lett. 2001, 11, 2397–2399; c) A. Morrell, M.
Placzek, S. Parmley, S. Antony, T. S. Dexheimer, Y.
Pommier, M. Cushman, J. Med. Chem. 2007, 50, 4419–
4430.
594
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 589 – 595